Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.07944 | 44 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.07048 | 46 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.07464 | 46 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.12676 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.99163 | 45 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.09075 | 43 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.12449 | 45 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.06522 | 46 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.06537 | 46 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.06945 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.05961 | 46 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.02749 | 45 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.0706 | 45 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.06545 | 46 |